cannabis

The House is not slowing down on the push for legalization of marijuana. There have been five bills introduced in the United States House of Representatives since the beginning of the 115th Congress (2017-2018). In addition, CO Representative, Jared Polis, has stated he will introduce his “Regulate Marijuana Like Alcohol Act” again this year. Four of the five bills were introduced by Republicans and one by Democrats, showing marijuana legalization is a bipartisan issue. All five bills are aimed at loosening federal restrictions on marijuana.

HR – 1227, titled “Ending Federal Marijuana Prohibition Act” was introduced on February 27, 2017 by Representative Thomas Garrett a Republican from Virginia. The text is the same as the Senate Bill introduced in 2015 (S. 2237) by Senator Bernie Sanders. The purpose is to remove “marihuana” and “tetrahydrocannabinols” from Schedule I of section 202(c) of the Controlled Substances Act (CSA). In 2017, Rep. Garrett’s bill is co-sponsored by six house members: Tulsi Gabbard (D-HI); Scott Taylor (R-VA); Jared Polis (D-CO); Earl Blumenauer (D-OR); Don Young (R-AK); Justin Amash (R-MI).

HR – 975, titled “Respect State Marijuana Laws Act of 2017” was introduced on February 7, 2017 by Representative Dana Rohrabacher a Republican from California. Rep. Rohrabacher introduced a “Respect State Marijuana Laws Act” in the 2013-2014 and 2015-2016.   The purpose is to amend the CSA for any provisions as related to marihuana.  The provisions shall not apply to any person who produces, possesses, distributes, dispenses, administers, or delivers marijuana in compliance with state law.  In 2017, Rep. Rohrabacher’s bill is co-sponsored by 14 house members:  Steve Cohen (D-TN); Don Young (R-AK); Mark Pocan (D-WI); Ted Yoho (R-FL); Earl Blumenauer (D-OR); Tom McClintock (R-CA); Dina Titus (D-NV); Duncan Hunter (R-CA); Jared Polis (D-CO); Justin Amash (R-MI); Barbara Lee (D-CA); Thomas Massie (R-KY); Mike Coffman (R-CO); Peter Welch (D-VT).

, Winn Halverhout and Fred Miles were interviewed by Advisory Board about the main challenges facing providers related to medical marijuana, how the new administration might change the legal landscape, and more.

Check out the article here.  Advisory Board is a best practices firm that uses a combination of research, technology, and consulting to improve

 in a case that potentially could have catastrophic effect on the cannabis industry.  At issue is whether the 10th Circuit Court of Appeals will allow private parties to sue state-licensed cultivations and dispensaries under RICO  for what are, essentially, nuisance issues.   Safe Streets, a Washington, D.C.-based anti-drug and anti-crime organization, filed the lawsuit and

The United States Patent and Trademark Office (“USPTO”) is at odds with the ever-growing marijuana industry. While marijuana legalization was a big winner in November’s elections, with seven states legalizing either medical or adult recreational use of the drug, the burgeoning industry may run into some problems obtaining trademarks for marijuana products and related devices. The lack of trademark protection could slow down or inhibit the growth of the industry as the lack of trademark protection limits entrepreneurs’ ability to stop infringement and protect their rights.

According to a prominent cannabis advisory firm, the cannabis industry raised over a $1 Billion in investment dollars in 2016.  These investments included public companies on the TSXV (cultivation and extract company), NYSE (REIT) and NASDAQ (pharmaceutical company).

What does this mean?

Majority of large investments are going into real estate and pharmaceutical company – as

Yesterday the DEA published a final rule providing for a new drug code for “Marihuana Extract” .  The DEA states that this will allow them to track quantities of “Marihuana Extract” separately from marijuana to aid in the compliance with relevant drug treaties.  This new rule is set to become effective on January 13, 2017.  The

California, Massachusetts, Nevada and Maine approved adult-use marijuana initiatives last night. Florida, North Dakota and Arkansas also approved medical marijuana initiatives. Unfortunately, Arizona failed to garner enough support to pass adult-use. Clearly, these votes are a watershed moment for cannabis reform in the United States. As I have stated before, California passing adult-use marijuana will likely signal the true beginning to the end of federal prohibition of marijuana. However, Donald Trump also pulled off a monumental victory for the GOP and won the White House which has created uncertainty for the industry.

What does this mean?

With the approval of adult-use marijuana in the states, the percentage of Americans living in states where marijuana use is legal for adults rose above 20 percent, from 5 percent. A recent Gallup Poll found nationwide support for legalization at 60%, the highest it likely has ever been. Florida passed its’ initiative by a 71% – Florida also voted for Trump.

As we all know, Trump is a wild card but he has not publicly taken any prohibitionist stance on cannabis. Trump recently was quoted as: “In terms of marijuana and legalization, I think that should be a state issue, state-by-state,” Trump told The Washington Post. “… Marijuana is such a big thing. I think medical should happen — right? Don’t we agree? I think so. And then I really believe we should leave it up to the states.”

Jeff Tyler put together a great segment for yesterday’s Marketplace podcast concerning the growing size (and sophistication) of the marijuana industry. This is one of many recent stories from larger media outlets that, like the industry itself, is moving away from the novelty of marijuana and treating it like any other business segment. You can